Archives of Cardiovascular Diseases
Scope & Guideline
Pioneering research and collaboration in cardiology.
Introduction
Aims and Scopes
- Clinical Cardiology and Management:
Focused on the diagnosis, treatment, and management of cardiovascular diseases, including acute and chronic conditions such as coronary artery disease, heart failure, and arrhythmias. - Cardiovascular Imaging and Diagnostics:
Dedicated to advancements in imaging techniques and diagnostic methodologies, including echocardiography, cardiac magnetic resonance imaging, and novel biomarker assessments. - Interventional Cardiology:
Covers research related to catheter-based interventions, transcatheter aortic valve implantation (TAVI), and other minimally invasive procedures for treating cardiovascular diseases. - Cardiovascular Pharmacotherapy:
Explores the use of pharmacological agents in managing cardiovascular conditions, including the efficacy and safety of new drugs and treatment regimens. - Epidemiology and Public Health:
Investigates the epidemiological trends, risk factors, and public health implications of cardiovascular diseases, contributing to a better understanding of disease prevention and management strategies. - Innovative Therapies and Technologies:
Focuses on the development and evaluation of innovative therapies, including gene therapy, stem cell treatments, and emerging technologies in cardiovascular care.
Trending and Emerging
- Remote Monitoring and Telemedicine:
With the rise of digital health technologies, there is an increasing focus on remote monitoring of patients with cardiovascular diseases, particularly in the context of managing chronic conditions and during the COVID-19 pandemic. - Artificial Intelligence and Machine Learning:
The application of AI and machine learning in predicting cardiovascular events and outcomes is gaining prominence, showcasing the integration of advanced analytics in clinical cardiology. - Personalized and Precision Medicine:
Emerging research is emphasizing personalized treatment approaches based on genetic, biomarker, and patient-specific data, aimed at optimizing therapeutic outcomes in cardiovascular care. - Cardiovascular Outcomes in Cancer Patients:
Research investigating the intersection between cardiovascular health and cancer management is becoming increasingly relevant, particularly as survival rates improve and long-term cardiovascular risks are recognized. - Heart Failure with Preserved Ejection Fraction (HFpEF):
The focus on HFpEF is growing, with studies exploring its pathophysiology, management strategies, and the impact of comorbidities, reflecting an urgent need to address this complex condition.
Declining or Waning
- Traditional Risk Factor Studies:
Research focusing solely on traditional cardiovascular risk factors, such as hypertension and hyperlipidemia, has seen a decline as newer studies explore more complex interactions and novel risk factors. - Historical Perspectives on Cardiovascular Diseases:
Papers that provide historical overviews or retrospective analyses of cardiovascular disease management are less frequent, possibly overshadowed by contemporary and forward-looking research. - Single-Center Studies:
The prevalence of single-center studies appears to be waning as multicenter and collaborative research efforts gain traction, providing more robust and generalizable findings. - Basic Science Research:
There is a noticeable decrease in publications focused solely on basic science and laboratory studies, as the emphasis shifts towards translational research that bridges laboratory findings with clinical applications. - Non-Cardiovascular Comorbidity Research:
Research examining comorbidities that are not directly related to cardiovascular outcomes has diminished, with a stronger focus on the interplay between cardiovascular diseases and other systemic conditions.
Similar Journals
CARDIOLOGY CLINICS
Advancing cardiovascular knowledge for a healthier tomorrow.CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.
AMERICAN JOURNAL OF CARDIOLOGY
Driving Innovation in Heart Health and Clinical OutcomesThe American Journal of Cardiology is a leading peer-reviewed journal in the field of Cardiology and Cardiovascular Medicine, published by Excerpta Medica Inc-Elsevier Science Inc. Since its inception in 1958, the journal has consistently contributed to the advancement of cardiovascular research, providing a platform for groundbreaking studies and clinical findings that shape modern medical practices. With an impressive impact factor placing it in the Q1 category in its field for 2023, it ranks among the top journals in medicine, with a rank of #155 out of 387 in the Scopus database, reflecting its significance and rigorous editorial standards. The journal is committed to disseminating high-quality research that fosters innovation and enhances clinical outcomes in cardiology. Although it does not provide Open Access options, the American Journal of Cardiology remains an essential resource for researchers, healthcare professionals, and students looking to deepen their understanding of cardiovascular health.
Journal of Cardiovascular Medicine
Empowering Clinicians with Cutting-Edge Cardiovascular ResearchWelcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.
Journal of Cardiology
Innovating solutions for a world of cardiovascular challenges.Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.
Arquivos Brasileiros de Cardiologia
Exploring the frontiers of cardiovascular science since 1950.Arquivos Brasileiros de Cardiologia is a leading open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine. Established in 1950 and published by the ARQUIVOS BRASILEIROS CARDIOLOGIA, this Brazilian journal plays a crucial role in disseminating high-quality research that addresses both emerging and established topics in cardiovascular science. With an impressive history and a commitment to open access since 1997, it provides researchers, healthcare professionals, and students with free and readily available content that significantly contributes to the understanding and management of cardiovascular diseases. The journal is indexed in Scopus and holds a Q3 ranking in the category of Cardiology and Cardiovascular Medicine, demonstrating its relevance and participation within the global research community. Researchers can submit their work and access a wealth of information that spans a variety of subfields, reflecting the journal’s dedication to fostering innovation and collaboration within cardiology. With a mailing address at Avenida Marechal Câmara, 160-330 Centro, Rio de Janeiro, RJ 20,020-907, Brazil, the journal continues to serve as a vital platform for scholarly communication and knowledge exchange in the cardiovascular realm.
Journal of the Saudi Heart Association
Transforming Heart Health Through Scholarly ExcellenceThe Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.
Journal of Cardiovascular Development and Disease
Leading the charge in cardiovascular research and discovery.Journal of Cardiovascular Development and Disease, an esteemed publication by MDPI, has been a dedicated platform for disseminating cutting-edge research since its inception in 2014. Based in Switzerland, this Open Access journal not only provides unrestricted access to its content but also fosters global collaboration among scholars focusing on cardiovascular health and disease development. With an impressive focus classified as Q1 in Pharmacology, Toxicology and Pharmaceutics for 2023, it attracts a diverse range of interdisciplinary research, supporting advancements in pharmacological applications relevant to cardiac conditions. The journal's ongoing convergence through 2024 highlights its commitment to the evolving landscape of cardiovascular research, making it a vital resource for researchers, professionals, and students alike who are keen to contribute to and learn from significant developments in this critical field.
ACTA CARDIOLOGICA
Advancing cardiovascular knowledge since 1946.ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.
TEXAS HEART INSTITUTE JOURNAL
Illuminating the Future of Cardiovascular Medicine.TEXAS HEART INSTITUTE JOURNAL, published by the renowned Texas Heart Institute, stands as a pivotal resource in the field of cardiology and cardiovascular medicine. With a history spanning over four decades since its establishment in 1982, this journal addresses a wide range of topics within its scope, including clinical studies, innovative treatments, and groundbreaking research in heart health. Despite its Q3 ranking in both Cardiology and Cardiovascular Medicine, the journal is committed to fostering advancement in medical knowledge and practice, providing an essential platform for healthcare professionals and researchers alike. While currently lacking open access, the journal is recognized for its contributions to the field, aiming to illuminate critical healthcare discussions and promote the exchange of ideas. For those interested in staying at the forefront of cardiovascular research, TEXAS HEART INSTITUTE JOURNAL offers invaluable insights and the latest developments shaping the future of heart care.
Minerva Cardiology and Angiology
Connecting research and clinical excellence in cardiology.Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.